Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.70 is 48% below its 5-year average of 5.17, near the low end of its 5-year range (1.39–8.77).
As of the fiscal period ended Tuesday, June 30, 2026. 22.75% above its 12-month average of 2.20.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.70.
QUICK RATIO (ACID-TEST)
2.70
QUICK RATIO (ACID-TEST) AVG TTM
2.20
QUICK RATIO (ACID-TEST) AVG 3Y
3.57
QUICK RATIO (ACID-TEST) AVG 5Y
5.17
QUICK RATIO (ACID-TEST) AVG 10Y
5.48
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+22.75%
CURRENT VS 3Y AVG
-24.24%
CURRENT VS 5Y AVG
-47.72%
CURRENT VS 10Y AVG
-50.71%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.20
median of 785 covered companies
CURRENT VS SECTOR MEDIAN
-15.57%
vs the sector median at left
Market Cap
$1.81B
Quick Ratio (Acid-Test)
8.30
TTM Avg
3.78
3Y Avg
3.78
5Y Avg
3.78
Market Cap
$1.81B
Quick Ratio (Acid-Test)
2.62
TTM Avg
2.33
3Y Avg
2.98
5Y Avg
3.78
Market Cap
$1.82B
Quick Ratio (Acid-Test)
13.96
TTM Avg
11.13
3Y Avg
7.91
5Y Avg
6.39
Market Cap
$1.79B
Quick Ratio (Acid-Test)
10.63
TTM Avg
5.62
3Y Avg
5.25
5Y Avg
6.00
Market Cap
$1.77B
Quick Ratio (Acid-Test)
1.70
TTM Avg
1.79
3Y Avg
1.95
5Y Avg
2.14
Market Cap
$1.85B
Quick Ratio (Acid-Test)
21.18
TTM Avg
6.27
3Y Avg
4.65
5Y Avg
4.09
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Novocure Ltd (NVCR) | $1.81B | 2.70 | 2.20 | 3.57 | 5.17 |
| Generate Biomedicines, Inc. (GENB)vs › | $1.81B | 8.30 | 3.78 | 3.78 | 3.78 |
| Sarepta Therapeutics, Inc. (SRPT)vs › | $1.81B | 2.62 | 2.33 | 2.98 | 3.78 |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.82B | 13.96 | 11.13 | 7.91 | 6.39 |
| Absci Corporation (ABSI)vs › | $1.79B | 10.63 | 5.62 | 5.25 | 6.00 |
| Azenta, Inc. (AZTA)vs › | $1.84B | 2.21 | 3.08 | 5.65 | 4.53 |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.77B | 1.70 | 1.79 | 1.95 | 2.14 |
| Novavax, Inc. (NVAX)vs › | $1.84B | 2.30 | 1.54 | 1.10 | 1.25 |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.85B | 21.18 | 6.27 | 4.65 | 4.09 |
| Astrana Health, Inc. (ASTH)vs › | $1.85B | 1.23 | 1.57 | 2.04 | 2.44 |
Quick Ratio
2.70
Excludes inventory
Current Ratio
2.89
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.70 |
| 2026-03-31 | 2.70 |
| 2025-12-31 | 2.71 |
| 2025-09-30 | 1.50 |
| 2025-06-30 | 1.39 |
| 2025-03-31 | 1.41 |
| 2024-12-31 | 1.42 |
| 2024-09-30 | 1.44 |
| 2024-06-30 | 6.22 |
| 2024-03-31 | 5.99 |
| 2023-12-31 | 5.56 |
| 2023-09-30 | 6.43 |
| 2023-06-30 | 6.88 |
| 2023-03-31 | 7.11 |
| 2022-12-31 | 6.82 |
| 2022-09-30 | 7.62 |
| 2022-06-30 | 7.87 |
| 2022-03-31 | 8.23 |
| 2021-12-31 | 7.36 |
| 2021-09-30 | 8.40 |
| 2021-06-30 | 8.77 |
| 2021-03-31 | 8.94 |
| 2020-12-31 | 8.56 |
| 2020-09-30 | 3.74 |
| 2020-06-30 | 5.42 |
| 2020-03-31 | 5.22 |
| 2019-12-31 | 4.82 |
| 2019-09-30 | 4.76 |
| 2019-06-30 | 4.68 |
| 2019-03-31 | 4.39 |
| 2018-12-31 | 4.63 |
| 2018-09-30 | 5.72 |
| 2018-06-30 | 5.97 |
| 2018-03-31 | 5.86 |
| 2017-12-31 | 4.44 |
| 2017-09-30 | 5.30 |
| 2017-06-30 | 6.01 |
| 2017-03-31 | 6.82 |
| 2016-12-31 | 6.41 |
| 2016-09-30 | 8.33 |
| 2016-06-30 | 6.17 |
| 2016-03-31 | 8.40 |
| 2015-12-31 | 9.79 |
| 2015-09-30 | 5.70 |
| 2015-06-30 | 7.75 |
| 2015-03-31 | 6.68 |
| 2014-12-31 | 6.13 |
| 2014-09-30 | 0.00 |
| 2014-06-30 | 0.00 |
| 2014-03-31 | 0.00 |
